BioWorld MedTech

Sep. 25, 2013

AdvaMed 2013: Market projected to achieve global sales of $455B in 2018

WASHINGTON — While 2013 has been a rough year for the med-tech market, a report from EvaluateMedTech forecasts happier days ahead, with the industry approaching $455 billion in global sales in 2018. Read More

AdvaMed 2013: Silverman; measures tough to come by for quality initiative

FDA revises Sapien labeling, expanding patient population

Solana launches FuseFORCE SuperElastic fixation system

Report from Europe: LabStyle gets CE mark for its Dario glucose monitor

Deals roundup: Greenway acquires Vitera in transaction for $644 million

Patent watch: HiberGene Diagnostics secures patent for Meningoccus test

People in Places

Financings roundup: Ventas reveals pricing of senior notes offering

Agreements/contracts: Piedmont Healthcare, Vanderbilt in pact to deploy CaseXpertSM

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 27, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Muted and missing M&As: JPM deals absent in 2026

BioWorld

For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...